Introduction: Neoadjuvant chemotherapy (NAC) is a cornerstone in breast cancer treatment, particularly for locally advanced, triple-negative, and human epidermal growth factor receptor 2 (HER2)-positive disease. However, concerns remain regarding the oncologic safety of breast-conserving surgery (BCS) following NAC com...
A. D. Nascimento Lima, A. Matter, F. Cavalcante et al.· Mastology· 0 citations
Introduction: The role of postmastectomy radiotherapy (PMRT) after neoadjuvant chemotherapy in patients who achieve nodal pathologic complete response (ypN0) remains controversial. As locoregional recurrence risk is low in this setting, the magnitude of benefit from PMRT is uncertain.
Objective: To evaluate the impact...
Marcelo Antoninni, A. Mattar, F. Cavalcante et al.· Mastology· 0 citations
Background: As the breast cancer population ages, understanding how age influences treatment decisions and survival in real-world settings becomes increasingly relevant. Age-related differences in clinicopathological features, treatment patterns, and outcomes were evaluated among women with surgically treated invasive...
M. Antonini, L. Silva, A. Mattar et al.· Mastology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.